Back to Search
MARK LITZOW, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1871579672Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
26419(MN)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
26419(MN)
Research & Publications (20)
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Progress and strategies for patients with relapsed and refractory acute myeloid leukemia.
PMID 17255790·Curr Opin Hematol·2007
6-review
Is autologous progenitor cell mobilization getting any easier?
PMID 18067002·Leuk Lymphoma·2007
8-other
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML.
PMID 16793737·Cytotherapy·2006
3-trial
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
PMID 16870552·Haematologica·2006
3-trial
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission.
PMID 12472596·Br J Haematol·2002
4-observational
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
PMID 12533034·Leuk Lymphoma·2002
8-other
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.
PMID 19250674·Leuk Res·2009
4-observational
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
PMID 19244158·Blood·2009
4-observational
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.
PMID 18997825·Bone Marrow Transplant·2009
4-observational
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
PMID 19059878·Blood·2009
4-observational
Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine.
PMID 19157545·Leuk Res·2009
3-trial
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
PMID 19330657·Leuk Lymphoma·2009
8-other
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
PMID 18981462·J Clin Oncol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1871579672
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile